Alex Goldberg

NASDAQ Gainers Watch List: First Solar, Inc. (NASDAQ:FSLR) and Cell Therapeutics, Inc. (NASDAQ:CTIC) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/10/2014 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding First Solar, Inc. (NASDAQ:FSLR) and Cell Therapeutics, Inc. (NASDAQ:CTIC).

First Solar, Inc. (NASDAQ:FSLR) a company that provides solar energy solutions is currently up (+2.37%) on 1,877,878 shares traded. First Solar, Inc. (NASDAQ:FSLR) is currently up (+110.47%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about First Solar, Inc. (NASDAQ:FSLR)

Cell Therapeutics, Inc. (NASDAQ:CTIC) a company that acquires, develops, and commercializes treatments for cancer is currently up (+3.90%) on 5,762,901 shares traded. Cell Therapeutics, Inc. (NASDAQ:CTIC) is currently up (+270.1%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Cell Therapeutics, Inc. (NASDAQ:CTIC)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com